CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - OSL:CONTX - SE0014731154 - Common Stock
3.38 NOK
-0.03 (-0.88%)
Taking everything into account, CONTX scores 6 out of 10 in our fundamental rating. CONTX was compared to 11 industry peers in the Health Care Technology industry. CONTX gets an excellent profitability rating and is at the same time showing great financial health properties. CONTX has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
In the past year CONTX had a positive cash flow from operations.
CONTX had positive earnings in 4 of the past 5 years.
CONTX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.66%, CONTX is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
CONTX's Return On Equity of 10.25% is fine compared to the rest of the industry. CONTX outperforms 63.64% of its industry peers.
The Return On Invested Capital of CONTX (8.96%) is better than 81.82% of its industry peers.
CONTX had an Average Return On Invested Capital over the past 3 years of 36.72%. This is significantly above the industry average of 8.99%.
The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(8.96%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROIC | 8.96% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX has a better Profit Margin (7.86%) than 63.64% of its industry peers.
CONTX's Profit Margin has improved in the last couple of years.
CONTX has a Operating Margin of 9.33%. This is in the better half of the industry: CONTX outperforms 63.64% of its industry peers.
CONTX's Operating Margin has improved in the last couple of years.
CONTX's Gross Margin of 97.46% is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
CONTX has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
The debt/assets ratio for CONTX is higher compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of CONTX is 1.49, which is an excellent value as it means it would take CONTX, only 1.49 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 1.49, CONTX is doing good in the industry, outperforming 63.64% of the companies in the same industry.
CONTX has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.07, CONTX is doing good in the industry, outperforming 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | N/A |
ROIC/WACC1.27
WACC7.05%
2.3 Liquidity
A Current Ratio of 4.12 indicates that CONTX has no problem at all paying its short term obligations.
CONTX has a better Current ratio (4.12) than 100.00% of its industry peers.
CONTX has a Quick Ratio of 4.07. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
CONTX's Quick ratio of 4.07 is amongst the best of the industry. CONTX outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 |
3. Growth
3.1 Past
The earnings per share for CONTX have decreased strongly by -64.19% in the last year.
CONTX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 27.26% yearly.
CONTX shows a decrease in Revenue. In the last year, the revenue decreased by -9.99%.
Measured over the past years, CONTX shows a small growth in Revenue. The Revenue has been growing by 6.51% on average per year.
EPS 1Y (TTM)-64.19%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-12.48%
3.2 Future
CONTX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.57% yearly.
The Revenue is expected to grow by 0.49% on average over the next years.
EPS Next Y-100%
EPS Next 2Y-33.05%
EPS Next 3Y-3.57%
EPS Next 5YN/A
Revenue Next Year-6.41%
Revenue Next 2Y-2.61%
Revenue Next 3Y-1.08%
Revenue Next 5Y0.49%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 26.00, the valuation of CONTX can be described as expensive.
CONTX's Price/Earnings ratio is a bit cheaper when compared to the industry. CONTX is cheaper than 63.64% of the companies in the same industry.
CONTX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.07.
Based on the Price/Forward Earnings ratio of 23.65, the valuation of CONTX can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CONTX indicates a somewhat cheap valuation: CONTX is cheaper than 63.64% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CONTX to the average of the S&P500 Index (34.08), we can say CONTX is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26 | ||
| Fwd PE | 23.65 |
4.2 Price Multiples
CONTX's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as CONTX.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.67 | ||
| EV/EBITDA | 9.97 |
4.3 Compensation for Growth
The excellent profitability rating of CONTX may justify a higher PE ratio.
CONTX's earnings are expected to decrease with -3.57% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.95
EPS Next 2Y-33.05%
EPS Next 3Y-3.57%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
The stock price of CONTX dropped by -23.68% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CONTX's Dividend Yield is rather good when compared to the industry average which is at 3.62. CONTX pays more dividend than 81.82% of the companies in the same industry.
CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-33.05%
EPS Next 3Y-3.57%
OSL:CONTX (11/20/2025, 7:00:00 PM)
3.38
-0.03 (-0.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap261.51M
Revenue(TTM)119.16M
Net Income(TTM)9.36M
Analysts40
Price Target5.1 (50.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.27%
Min EPS beat(2)-148.54%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.12%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)100%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26 | ||
| Fwd PE | 23.65 | ||
| P/S | 2.06 | ||
| P/FCF | 41.67 | ||
| P/OCF | 17.97 | ||
| P/B | 2.68 | ||
| P/tB | 2.77 | ||
| EV/EBITDA | 9.97 |
EPS(TTM)0.13
EY3.85%
EPS(NY)0.14
Fwd EY4.23%
FCF(TTM)0.08
FCFY2.4%
OCF(TTM)0.19
OCFY5.56%
SpS1.64
BVpS1.26
TBVpS1.22
PEG (NY)N/A
PEG (5Y)0.95
Graham Number1.92
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROCE | 11.34% | ||
| ROIC | 8.96% | ||
| ROICexc | 31.76% | ||
| ROICexgc | 35.3% | ||
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% | ||
| FCFM | 4.93% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 96.94% | ||
| Cap/Sales | 6.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.3% | ||
| Profit Quality | 62.81% | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 | ||
| Altman-Z | N/A |
F-Score5
WACC7.05%
ROIC/WACC1.27
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.19%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
EPS Next Y-100%
EPS Next 2Y-33.05%
EPS Next 3Y-3.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-12.48%
Revenue Next Year-6.41%
Revenue Next 2Y-2.61%
Revenue Next 3Y-1.08%
Revenue Next 5Y0.49%
EBIT growth 1Y-64.61%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-32.14%
EBIT Next 3Y9.74%
EBIT Next 5YN/A
FCF growth 1Y-82.88%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-68.39%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CONTX.OL.
What is the valuation status of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a valuation rating of 4 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Fairly Valued.
How profitable is CONTEXTVISION AB (CONTX.OL) stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 8 / 10.
How financially healthy is CONTEXTVISION AB?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 7 / 10.
Can you provide the expected EPS growth for CONTX stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -100% in the next year.